NGL FINECHEM
|
The Current P/S Ratio of NGL FINECHEM is 2.70.
Share Price | ₹1,619.2 | Feb 01,2025 |
Market Cap | ₹1,003.9 Cr | |
Sales-TTM | ₹372.0 Cr | TTM-Consolidated Results |
Price/Sales | 2.70x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of NGL FINECHEM
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,003.9 Cr] as on Feb 01,2025
(/) Sales [ ₹372.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.70x ]
Thus, for NGL FINECHEM , the investors are currently willing to pay '2.70 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of NGL FINECHEM !
The chart below summarizes the trend in P/S Ratio of NGL FINECHEM over the last five years.
Historical PS (Price/Sales) ratio chart of NGL FINECHEM
PS Ratio Performance Analysis for NGL FINECHEM
- NGL FINECHEM 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.00x.
- NGL FINECHEM 's operated at median p/e ratio of 3.67x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NGL FINECHEM 's p/e ratio peaked in Mar2024 at 3.81x.
- NGL FINECHEM 's p/e ratio hit its five-year low in Mar2020 of 1.03x.
How does NGL FINECHEM 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
NGL FINECHEM | 372.0 | 2.70 | 1,003.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 8.10 | 418,132.0 |
CIPLA LTD | 26,981.2 | 4.30 | 116,123.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.22 | 100,573.0 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.56 | 97,966.9 |
DIVIS LABORATORIES LTD | 8,614.0 | 17.33 | 149,254.0 |
MANKIND PHARMA LTD | 11,641.0 | 8.79 | 102,348.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.60 | 108,477.0 |
LUPIN LTD | 21,431.3 | 4.38 | 93,813.7 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.19 | 66,385.6 |
ABBOTT INDIA LTD | 6,066.1 | 9.08 | 55,059.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs NGL FINECHEM 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.19x |
Max industry PS | 17.33x |
Median industry PS | 4.56x |
Average industry PS | 6.75x |
You may also like the below Video Courses